Adrenal involvement in multiple endocrine neoplasia type 1

World Journal of Surgery

Volumn 26, Issue 8, 2002, Pages 891-896

  Langer, Peter ^a   Cupisti, Kenko ^b   Bartsch, Detlef K ^a   Nies, Christoph ^a   Goretzki, Peter E ^b   Rothmund, Matthias ^a   Röher, Hans D ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL DISEASE; ADRENAL TUMOR; ADRENALECTOMY; ADULT; AGED; CONFERENCE PAPER; CUSHING SYNDROME; DISEASE COURSE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; PREVALENCE; SCREENING; ADOLESCENT; ARTICLE; EXON; GENETICS; INTRON; MIDDLE AGED; MUTATION; PATHOLOGY; PHENOTYPE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; EXONS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PHENOTYPE; PREVALENCE;

EID: 0036688509     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6492-4     Document Type: Conference Paper

References (31)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 1954;16:363-375
2. Duh QY, Hybarger CP, Geist R, et al. Carcinoids associated with multiple endocrine neoplasia syndromes. Am. J. Surg. 1987;154:142-148
3. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN 1). Q. J. Med. 1996;89:653-669
4. Eberle G, Gruen R. Multiple endokrine neoplasie typ 1 (MEN 1). Ergebn. Int. Med. Kinderheilkd. 1981;46:76-149
5. Ballard HS, Frame B, Hartstock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 1964;43:481-516
6. Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 1998;124:1106-1113
7. Croisier JC, Azérad E, Lubetzki J. L'adénomatose polyendocrinienne (syndrome de Wermer). Semin, Hop. Paris 1971;47:494-525
8. Skogseid B, Larsson C, Lindgren PG, et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 1992;75:76-81
9. Skogseid B, Rastad J, Gobl A, et al. Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 1995;118:1077-1082
10. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia - type 1. Science 1997;276:404-407
11. Agarwal SK, Guru SC, Heppner C, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999;96:143-152
12. Bartsch D, Kopp I, Bergenfelz A, et al. MEN1 gene mutations in 12 MEN1 families and their associated tumours. Eur. J. Endocrinol. 1998;139:416-420
13. Cupisti K, Hoppner W, Dotzenrath C, et al. Lack of MEN 1 gene mutations in 27 sporadic insulinomas. Eur. J. Clin. Invest. 2000;30:325-329
14. Hoeppner W, Ritter MM. A duplication of 12bp in the critical cystein rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A. Hum. Mol. Genet. 1997;6:587-590
15. Burgess JR, Harle RA, Parameswaran V, et al. Adrenal lesion in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg. 1996;131:699-702
16. Giraud S, Zhang CX, Serova-Sinilnikova O, et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 1998;63:455-467
17. Kopp I, Bartsch D, Wild A, et al. Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families. World J. Surg. 2001;25:610-616
18. Carney JA, Go VL, Gordon H, et al. Familial pheochromocytoma and islet cell tumor of the pancreas. Am. J. Med. 1980;68:515-521
19. Myers JH, Eversman JJ. Acromegaly, hyperparathyroidism, and pheochromocytoma in the same patient. Arch. Intern. Med. 1981;141:1521-1522
20. Dackiw AP, Cote GJ, Fleming JB, et al. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery 1999;126:1097-1103
21. Beckers A, Abs R, Willems PJ, et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN 1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN 1 locus. J. Clin. Endocrinol. Metab. 1992;75:564-570
22. Ferris JB, Brown JJ, Cumming AMM, et al. Primary hyperparathyroidism associated with primary hyperaldosteronism. Acta Endocrinol. (Copenh.) 1983;103:365-370
23. Herd GW. A case of primary hyperparathyroidism, primary hyperaldosteronism and Cushing's disease. Acta Endocrinol. (Copenh.) 1984;107:371-374
24. Görtz B, Roth J, Speel EJM, et al. MEN 1 gene mutation analysis of sporadic adrenocortical lesions. Int. J. Cancer 1999;80:373-379
25. Heppner C, Reincke M, Agarwal SK, et al. MEN 1 gene analysis in sporadic adrenocortical neoplasms. J. Clin. Endocrinol. Metab. 1999;84:216-219
26. Schulte KM, Heinze M, Mengel M, et al. MEN I gene mutations in sporadic adrenal adenomas. Hum. Genet. 1999;105:603-610
27. Zwermann O, Beuschlein F, Mora P, et al. Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur. J. Endocrinol. 2000;142:689-695
28. Reincke M, Beuschlein F, Slawik M, et al. Molecular adrenocortical tumourigenesis. Eur. J. Clin. Invest. 2000;30(Suppl. 3):63-68
29. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000;128:958-966
30. Gobl AE, Berg M, Lopez-Egido JR, et al. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim. Biophys. Acta 1999;1447:51-56
31. Cupisti K, Simon D, Dotzenrath C, et al. MEN I-assoziiertes Nebennierenrindenkarzinom bei Nebennierenrindenhyperplasie'. Acta Chir. Austriaca 1996;4:242-244